| Bioactivity | CpCDPK1/TgCDPK1-IN-2 (Compound 7r) is a CpCDPK1 and TgCDPK1 inhibitor with IC50 values of 12 and 5 nM, respectively. CpCDPK1/TgCDPK1-IN-2 can be used in the research of apicomplexan protozoa-related diseases, such as the research of T. gondii, C. parvum and C. hominus infection[1]. |
| Name | CpCDPK1/TgCDPK1-IN-2 |
| CAS | 1236038-23-5 |
| Formula | C20H21N5O |
| Molar Mass | 347.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wesley C. Van Voorhis, et al. Compositions And Methods For Treating Toxoplasmosis, Cryptosporidiosis, And Other Apicomplexan Protozoan Related Diseases. US20130018040A1. |
CpCDPK1/TgCDPK1-IN-2
CAS: 1236038-23-5 F: C20H21N5O W: 347.41
CpCDPK1/TgCDPK1-IN-2 (Compound 7r) is a CpCDPK1 and TgCDPK1 inhibitor with IC50 values of 12 and 5 nM, respectively. CpC
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.